Yew Bio-Pharm Group, Inc. Segment Reporting Information, Expenditures for Additions to Long-Lived Assets (Deprecated 2013-01-31)
Yew Bio-Pharm Group, Inc. reported Segment Reporting Information, Expenditures for Additions to Long-Lived Assets (Deprecated 2013-01-31) of $706.04 thousand for the 12-month period ending 2012-12-31, per its 10-Q filed 2013-05-14.
Discontinued › Notes
us-gaap:AdditionsToNoncurrentAssets · last filed 2013-05-14
- Yew Bio-Pharm Group, Inc. segment reporting information, expenditures for additions to long-lived assets (deprecated 2013-01-31) for the quarter ending 2012-12-31 was $431.77K.
- Yew Bio-Pharm Group, Inc. segment reporting information, expenditures for additions to long-lived assets (deprecated 2013-01-31) for the quarter ending 2012-09-30 was $227.97K.
- Yew Bio-Pharm Group, Inc. segment reporting information, expenditures for additions to long-lived assets (deprecated 2013-01-31) for fiscal 2011 was $5.71M.
| Period end | Segment Reporting Information, Expenditures for Additions to Long-Lived Assets (Deprecated 2013-01-31) 3 month | Segment Reporting Information, Expenditures for Additions to Long-Lived Assets (Deprecated 2013-01-31) 6 month | Segment Reporting Information, Expenditures for Additions to Long-Lived Assets (Deprecated 2013-01-31) 9 month | Segment Reporting Information, Expenditures for Additions to Long-Lived Assets (Deprecated 2013-01-31) 12 month |
|---|---|---|---|---|
| 2012-12-31 | $431.77K derived: 10-Q 12 month − 10-Q 9 month · filed 2013-05-14 | $659.74K derived: sum of 2 quarters · filed 2013-05-14 | $706.04K 10-Q · filed 2013-05-14 | |
| 2012-09-30 | $227.97K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2012-11-13 | $274.27K 10-Q · filed 2012-11-13 | ||
| 2012-06-30 | $46.30K 10-Q/A · filed 2012-09-14 | |||
| 2011-12-31 | $5.71M 10-K · filed 2013-04-11 |